Sign in
Active, not recruitingNo phase

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

Key facts

Who runs it
Empirical Spine, Inc.
Where
Atlanta, Binghamton, Boston, Boulder, Carmel, Charlottesville, Chicago, Columbus, Louisville, Miami, New York, Oakland, Philadelphia, Plano, Redwood City, Royal Oak, Sacramento, San Francisco, San Jose, Santa Monica, Seattle, St Louis, Syracuse, Tampa, Tempe, Waterford, and Worcester, United StatesSee the 28 sites
Trial code
Status
Active, not recruiting
People taking part
299 people enrolled
Started
17 Jul 2017
Ended
16 Jan 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • LimiFlex
  • Fusion Instrumentation
  • Decompression
  • Fusion
Record updated
7 August 2025

Who can take part

Age
25 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 44 criteriaShow less

Who can take part

  • Lumbar degenerative spondylolisthesis (Grade I per Meyerding classification), at one level from L1 to S1, with radiographic confirmation using X-ray; Grade I spondylolisthesis per Meyerding classification includes up to 25% anterior translation of a vertebra relative to the superior endplate of the subjacent vertebra at the index level. A patient is considered to have spondylolisthesis with a minimum 10% anterolisthesis at the affected level in a lateral x-ray image
  • Lumbar spinal stenosis requiring decompression at up to two contiguous levels from L1 to S1, inclusive of the level diagnosed with degenerative spondylolisthesis, and confirmed radiographically using CT or MRI; At the index level, lumbar spinal stenosis is at least moderate lumbar canal stenosis, defined as more than 25% reduction of the cross-sectional area compared with the next adjacent normal level, with nerve root crowding compared with the normal level, as determined by the investigator on CT Scan or MRI
  • Neurogenic claudication or radiculopathy symptoms including leg pain, muscle weakness, and/or sensation abnormality, with or without back pain as evidenced by patient history
  • Persistent symptoms despite at least 3 months of conservative treatment that may include but is not limited to physical therapy, medications, and/or epidural injections
  • A pre-operative Visual Analog Scale (VAS) leg pain score of ≥50 on a 100 mm scale; Leg pain includes hip and/or buttock pain on the same side
  • A pre-operative Oswestry Disability Index (ODI) score ≥35 points on a 100-point scale
  • Candidate for surgical decompression at a single level or two contiguous levels, with stabilization at only one level between L1-S1
  • Posterior element anatomy is appropriate for interspinous fixation including prediction of presence of spinous processes of segment to be instrumented following decompression (investigational AND control groups) and a prediction of >50% of facet joints present following decompression (investigational group only)
  • ≥25-80 years of age and skeletally mature
  • Patient has the necessary mental capacity to participate and is willing and able to participate in the study for the duration of the study follow-up and is able to comply with study requirements; and
  • Patient is willing to provide Informed Consent for study participation

Who cannot take part

  • History of any previous surgery* at any level in the lumbosacral spine except for a discectomy or decompression
  • History of any previous surgery* at the level planned for treatment; previous surgery includes spinal stimulator placement but does NOT include epidural injections, rhizotomy or nerve ablation
  • Planned hip or knee replacement surgery, severe osteoarthritis or other musculoskeletal pathology of the hip or leg that could preclude reliable patient self reporting assessment scales and/or that would likely progress to surgery during study period
  • Receiving immunosuppressive or long-term steroid therapy
  • Currently seeking or receiving worker's compensation for back pain or spinal condition
  • Current involvement in a study of another investigational product for similar purpose
  • Significant peripheral vascular disease causing vascular claudication
  • Significant peripheral neuropathy caused by conditions other than spinal stenosis
  • History of fixed or permanent neurological deficit related to spinal cord injury
  • Spinous process insufficiency or deformity that would preclude secure fixation of the LimiFlex Device to the spinous process including spinous process length <10 mm from lamina to dorsal tip or other significant deformity due to trauma, or congenital abnormality such as spina bifida occulta at the planned instrumented level that would preclude secure fixation of the LimiFlex Device to the spinous process
  • Severe osteoporosis, defined as history of fragility fracture and DXA T-score <-2.5 or QCT T-score <80mg/cubic cm. History of a fragility fracture requires that a DXA scan or QCT scan is completed
  • Documented allergy to titanium or polyethylene
  • Active local or systemic infection
  • Known history of bone metabolic disorder, including Paget's disease, hyperparathyroidism, renal osteodystrophy, and osteomalacia
  • Active malignancy or history of metastatic malignancy within the last five years
  • Active treatment of a major psychiatric condition, such as major depression, anxiety disorder, bipolar disorder, schizophrenia, personality disorder, that could prevent accurate completion of self reporting assessment scales
  • Disease or condition that would preclude accurate clinical evaluation of the safety and effectiveness of the study treatment or any significant medical conditions which would place the patient at excessive risk for surgery, such as:; severe rheumatoid arthritis or other severe autoimmune disease; active hepatitis (viral or serum) or HIV positive; unstable cardiac disease; uncontrolled diabetes; renal failure; severe muscular, neural or vascular diseases that endanger the spinal column; cauda equina syndrome; severe neurologic disorders including paralysis
  • A primary and predominate diagnosis of discogenic back pain
  • A primary and predominate diagnosis of facet-mediated back pain
  • Back or non-radicular leg pain of unknown etiology
  • Isthmic spondylolisthesis or spondylolysis (pars fracture) at any level in the lumbar spine
  • Clinically significant compromise of vertebrae at L1 to S1 levels due to osteoporotic vertebral compression fracture or any traumatic, neoplastic, metabolic or infectious pathology or congenital abnormality
  • Spinous process fracture(s) or other posterior element fracture(s) of the segment to be instrumented that would preclude secure fixation of the LimiFlex Device to the spinous process
  • The estimated distance between the LimiFlex Device strap attachment points (midpoint of the cranial edge of the cranial spinous process and the midpoint of the caudal edge of the caudal spinous process) is <30mm on pre-operative lateral standing radiographs at the segment to be instrumented
  • Degenerative lumbar scoliosis with a Cobb angle >10° at the affected motion segment
  • Symptomatic lumbar stenosis that is not amenable to a direct decompression
  • Anklyosed motion segment at the target operative level
  • Morbid obesity defined as BMI >40
  • Women who are pregnant or are interested in becoming pregnant within the study period
  • Currently involved in spinal litigation that potentially is associated with secondary financial gain
  • Demonstrates three or more Waddell's Signs of Inorganic Behavior
  • Current history (within 12 months) of substance abuse, including alcohol abuse; or
  • A prisoner

Where in United States

  • Emory UniversityAtlanta, United States
  • UHS Neurosurgery (Binghamton)Binghamton, United States
  • Beth Israel Deaconess Medical CenterBoston, United States
  • Boulder Neurological & Spine AssociatesBoulder, United States
  • Indiana Spine GroupCarmel, United States
  • University of Virginia Orthopaedic SurgeryCharlottesville, United States
  • RUSH UniversityChicago, United States
  • The Ohio State UniversityColumbus, United States
  • Norton Leatherman Spine CenterLouisville, United States
  • University of Miami, Dept of Neurological SurgeryMiami, United States
  • Hospital for Special SurgeryNew York, United States
  • Kaiser Permanente Division of ResearchOakland, United States
  • University of Pennsylvania HospitalPhiladelphia, United States
  • Texas Back Institue, Clincal Research, LLC-PlanoPlano, United States
  • Stanford University Medical CenterRedwood City, United States
  • Beaumont HospitalRoyal Oak, United States
  • Kaiser Permanente Roseville Clinical Trials ProgramSacramento, United States
  • UC Davis Spine CenterSacramento, United States
  • UCSF Dept of Orthopaedic SurgerySan Francisco, United States
  • Kaiser Permanente - San Jose Medical CenterSan Jose, United States
  • The Spine Institute, Center for Spinal Restoration and Foundation for Spinal RestorationSanta Monica, United States
  • Swedish Medical CenterSeattle, United States
  • Washington University School of MedicineSt Louis, United States
  • SUNY Upstate Medical UniversitySyracuse, United States
  • BioSpineTampa, United States
  • Sonoran Spine Research and Education FoundationTempe, United States
  • Michigan Minimally Invasive Neurosurgical InstituteWaterford, United States
  • University of Massachusetts, Dept of Orthopedics and Physical RehabilitationWorcester, United States

About the trial

What the trial wants to find out

The LimiFlex™ Clinical Trial is a prospective, concurrently controlled, multi-center study to evaluate the safety and effectiveness of decompression and stabilization with the Empirical Spine LimiFlex™ Paraspinous Tension Band compared to decompression and transforaminal lumbar interbody fusion (TLIF) with concomitant posterolateral fusion (PLF) for the treatment of lumbar degenerative spondylolisthesis (Grade I per Meyerding classification) with spinal stenosis. Clinical trial sites will enroll solely LimiFlex subjects or solely TLIF/PLF subjects.

The 2 groups in the trial

  • LimiFlexTreatment being tested

    Posterior dynamic stabilization with the LimiFlex Paraspinous Tension Band

    Treatment: LimiFlex and Decompression

  • FusionExisting treatment, for comparison

    Transforaminal lumbar interbody fusion with concomitant posterolateral fusion with pedicle screw instrumentation

    Treatment: Fusion Instrumentation, Decompression, and Fusion

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Concurrently Controlled Study of the LimiFlex™ Paraspinous Tension Band in the Treatment of Lumbar Degenerative Spondylolisthesis With Spinal Stenosis
Publications
Record updated
7 August 2025